Research Article

Determine seroprevalence and associated risk factors of HBV infection among pregnant women and it relationship with blood transfusion at Hargeisa Group Hospital, Hargeisa, Somaliland

Abdullah Al-Mamari*

Published: 19 April, 2019 | Volume 3 - Issue 1 | Pages: 001-009

Background: The measures are being put in place for the management of Hepatitis B virus (HBV) infection in Hargeisa, Somaliland among pregnant women remain the most vulnerable to develop chronic hepatitis. Routine screening in pregnant women is therefore necessary for effective control. However, the performance of the commonly used the HBsAg sero test strips has been available. Also, identifying the risk factors of transmission in pregnant women is importance for the implementation of preventive measures. Hence, the goal of this study was to determining seroprevalence and associated risk factors with HBV infection among pregnant women.

Material & Methods: The study area was carried out at Hargeisa group hospital in Somaliland from May 2018 up to December 2018. The researcher was collected research pregnancy woman data through questionnaire & used diagnostics methods such as Hepatitis B surface antigen (HBsAg) test, antibodies test (HBsAb) by used anti-card test and ELIZA system. In order to find specific full information’s about patients & relationship the associated risk factors with hepatitis B in pregnancy. Data processed and analyzed by used both words and SPSS package. The sample size investigated was 80 patients. Of these, 28 were excluded; among the reasons for exclusion were prior HBV vaccination and known HBsAg sero-positive status.

Aims of Study: The study was designed & aimed to determine seroprevalence and associated factors of HBV infection among pregnant women. To assess and establish if there is significant relationship between blood transfusion and hepatitis B virus at Hargeisa group hospital (HGH).

Results and Discussion: The results in the current study shown that the pregnancy with hepatitis BV and it relation with appeared some symptoms in our study was 24(46.15%) of patients appeared they have cirrhosis symptom, 12(23.08%) of patients answered they have liver failure, while 9(17.31%) of patients appeared yellowish of eyes & skin and 5(9.62%) showed hepatic cancer.

Overall, HBV prevalence: HBsAg was detected in fifteen 15(31.3%) of the participants while all fifteen (100%) had total HBcAb (both IgM and IgG). Of the HBsAg sero-positive women, 26(42.7%) were positive for HBeAg; eight (13.3%) were positive for HBeAb and four 4(9%) were negative for both HBeAg and HBeAb which was close similar with other previous studies. On the other hand, We found identify statistically significant p-values < 0.05 and high relationship between HBV and some demographic and clinical risk factors such as blood transfusions, levels of knowledge about HBV infection in addition to age and marital status.

Conclusion: The results of this study showed that the seroprevalence of HBV infections in pregnant women and it relationship with blood transfusion in Hargeisa Group Hospital, Hargeisa, Somaliland is high. However, further studies are needed to assess the role of other demographic and clinical risk. Urgent action is required to improve hepatitis B infection control measures to reduce dependence on blood transfusions and make new policies for treatment of anemia in HGH

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001003 Cite this Article Read Full Article PDF


Hepatitis B; Pregnant women; Blood transfusion; Risk factors; Prevalence.


  1. Aali BS. The prevalence of HBsAg among pregnant women referred to Kerman maternity hospitals in 1997. J Kerman Univ Med Sci. 1999; 6: 89–96. Ref.: https://tinyurl.com/y4ogz42d
  2. Abram SB. Control of Communicable diseases Manual. 16th ed. Am Public Health Assoc. 1995: 250-252.
  3. Allain JP1, Candotti D, Soldan K, Sarkodie F, Phelps B, et.al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood. 2003; 101: 2419-2425. Ref.: https://tinyurl.com/y36of2fg
  4. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, et.al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006; 52: 202–206. Ref.: https://tinyurl.com/y3csusue
  5. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, et.al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990; 264: 2231–2235. Ref.: https://tinyurl.com/y29bzo5c
  6. Aweis D, Brabin BJ, Beeching NJ, Bunn JE, Cooper C, et al. Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool. Commun Dis Public Health. 2001; 4: 247-252. Ref.: https://tinyurl.com/y5wj7zck
  7. Awole M, Gebre-Selassie S. Seroprevalence of HbsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop J Health Dev. 2005; 19: 45-51. Ref.: https://tinyurl.com/yyphoe4s
  8. Bile K, Mohamud O, Aden C, Isse A, Norder H, et.al. The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions. Am J Trop Med Hyg. 1992; 47: 357-364. Ref.: https://tinyurl.com/y2hz62hj
  9. Beasley PR. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma, epidemiologic considerations. Hepatology 1982; (Suppl): 21S–6S. Ref.: https://tinyurl.com/y2d6eqd7
  10. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics. 2003; 111(Suppl1): 1192–1197. Ref.: https://tinyurl.com/y2jmjcrc
  11. Jaffari RM, Saadati N, Esfarjani SH, Cheshmeh AS. A survey of the frequency of HBsAg+status in pregnant women attending health centers in Ahwaz. Payesh. 2004; 3: 237–243. Ref.: https://tinyurl.com/yxoprd8g
  12. Jatau ED, Yabaya A. Seroprevalence of Hepatitis B virus in pregnant women attending a clinic in Zaria, Nigeria. Sci World J. 2004;4(2):7-9. Kitchen A. Hepatitis B and blood safety. Vaccine. 1998; 16: S34–S37. Ref.: https://tinyurl.com/y2xyy6zl
  13. Lewis-Ximenez LL, do OK, Ginuino, CF, Silva JC, Schatzmayr HG, et.al. Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil. BMC Public Health. 2002; 2: 26. Ref.: https://tinyurl.com/y6zpfjq4
  14. Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, et al. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol. 2008; 46: 754–756. Ref.: https://tinyurl.com/y2nj7qr9
  15. Mirghaforvand M, Montazam SH, Rafie A. Study of prevalence and contributing factors of hepatitis B among pregnant women referred to laboratory of health center of Bonab. J Urmia Nurs Midwifery Fac. 2007; 5: 120–131. Ref.: https://tinyurl.com/yyg6zxcs
  16. Moestrup T, Hansson BG, Widell A, Nordenfelt E, Hägerstrand I. Long term follow up of chronic hepatitis B virus infection in intravenous drug abusers and homosexual men. Br Med J. 1986; 292: 854–857. Ref.: https://tinyurl.com/y38pcge3
  17. Jonas MM. Hepatitis B and Pregnancy: An Underestimated Issue. Liv Int. 2009; 29(suppl1): 133-139. Ref.: https://tinyurl.com/y2zgxlvp
  18. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2009; 83: 485–493. Ref.: https://tinyurl.com/y4t2xt5c
  19. Okonko IO, Udeze AO. Detection of Hepatitis B surface antigen (HBsAg) among pregnant women attending Antenatal Clinic at OLA Catholic Hospital, Oluyoro, Ibadan, Oyo State, Southwestern Nigeria. Nat Sci. 2011; 9: 54-60. Ref.: https://tinyurl.com/y3qlzukr
  20. Phoon WO, Fong NP, Lee J. History of blood transfusion, tat­tooing, acupuncture and risk of hepatitis B surface antigen­aemia mong Chinese men in Singapore. Am J Public Health. 1988; 78: 958-960. Ref.: https://tinyurl.com/y62v4jjw
  21. Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO. Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet Gynecol Scand. 2010; 89: 1024–1028. Ref.: https://tinyurl.com/y6mppcmy
  22. Reynolds L, McKee M. Possible risks of transmission of blood borne infection via acupuncture needles in Guizhou province, southwest China. J Altern Complement Med. 2008; 14: 1281-1285. Ref.: https://tinyurl.com/y4aclylc
  23. Sharma R, Sharma CL, Khajuria R. The knowledge, attitude and practices regarding HBV infection of married women in the reproductive Age group living in cantonment Area Sunjawan Jammu. J Med Educ Res. 2004; 6: 127–130. Ref.: https://tinyurl.com/y4zumt9y
  24. Tran TT. Management of hepatitis B in pregnancy weighing the options. Cleve. Clin J Med. 2009; 76(Suppl 3): S25–S29. Ref.: https://tinyurl.com/yydg4c5u
  25. Waheed Y, Rahat T, Safi B, Qadri I. Epidemiological patterns and risk factors associated with hepatitis B virus in Pakistani population. Asian Biomedicine. 2010; 4: 547-551. Ref.: https://tinyurl.com/y5appl6l


Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More